Modalities

Large molecule or biologic drugs are a diverse class of compounds varying in size, complexity, and mode of action with broad therapeutic applications. Due to this wide range of large molecule therapeutic types, bioanalytical support for these drugs requires a CRO provider with a comprehensive depth of expertise across therapeutic modalities and a large selection of bioanalytical tools or resources.

We provide discovery bioanalysis (non-GLP), regulated bioanalysis, and high-throughput bioanalysis for small molecules to support the following therapeutic development studies: develop, validate, and perform laboratory developed tests (LDTs) and FDA-cleared assays.

Advanced Therapy Medicinal Products (ATMPs) are a novel area of therapeutics that includes many groundbreaking approaches to medical intervention for disease. Bioanalytical testing of ATMPs for safety and efficacy is an evolving field as the body of data on these modalities continues to grow.

Vaccine development is one of the most diverse and fastest growing areas in pharmaceuticals and biotechnology. The serious impacts of infectious diseases like Ebola, Malaria, HIV, and COVID-19 on world health have continued to make vaccines.